Journal article
Non-compliance: the Achilles' heel of anti-fracture efficacy
Abstract
About 50% of patients fail to comply or persist with anti-osteoporosis treatment regimens within 1 year. Poor compliance is associated with higher fracture rates. Causes of poor compliance are unknown. As it is not possible to predict poor compliance, close monitoring of compliance is needed. Despite evidence supporting the anti-fracture efficacy of several pharmacological agents, approximately 50% of patients do not follow their prescribed …
Authors
Seeman E; Compston J; Adachi J; Brandi ML; Cooper C; Dawson-Hughes B; Jönsson B; Pols H; Cramer JA
Journal
Osteoporosis International, Vol. 18, No. 6, pp. 711–719
Publisher
Springer Nature
Publication Date
June 2007
DOI
10.1007/s00198-006-0294-8
ISSN
0937-941X